Franciscus J A van den Hoogen
Overview
Explore the profile of Franciscus J A van den Hoogen including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
220
Followers
0
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
van Hulst K, Kouwenberg C, Jongerius P, Feuth T, van den Hoogen F, Geurts A, et al.
Dev Med Child Neurol
. 2016 Dec;
59(5):531-537.
PMID: 27901263
Aim: The aims of this study were: (1) to determine the incidence and nature of adverse effects on oral motor function after first injections of botulinum neurotoxin A (BoNT-A) in...
2.
Hoogsteen I, Marres H, van den Hoogen F, Rijken P, Lok J, Bussink J, et al.
Int J Radiat Oncol Biol Phys
. 2012 Mar;
84(3):807-14.
PMID: 22420963
Purpose: Overexpression of epidermal growth factor receptor (EGFR) and tumor hypoxia have been shown to correlate with worse outcome in several types of cancer including head-and-neck squamous cell carcinoma. Little...
3.
Coppen C, de Wilde P, Pop L, van den Hoogen F, Merkx M
Oral Oncol
. 2006 Mar;
42(8):795-9.
PMID: 16529979
The purpose of this study was to evaluate outcome and value of follow-up of squamous cell carcinoma (SCC) of the buccal mucosa in patients treated at the Radboud University Nijmegen...
4.
Hoogsteen I, Pop L, Marres H, Merkx M, van den Hoogen F, van der Kogel A, et al.
Int J Radiat Oncol Biol Phys
. 2005 Oct;
64(1):83-9.
PMID: 16213107
Purpose: To evaluate the prognostic significance of hemoglobin (Hb) levels measured before and during treatment with accelerated radiotherapy with carbogen and nicotinamide (ARCON). Methods And Materials: Two hundred fifteen patients...
5.
Hoogsteen I, Peeters W, Marres H, Rijken P, van den Hoogen F, van der Kogel A, et al.
Radiother Oncol
. 2005 Aug;
76(2):213-8.
PMID: 16112214
Background And Purpose: To evaluate erythropoietin receptor (EPOR) expression in human head and neck squamous cell carcinomas and correlate this to the presence of tumor hypoxia and treatment outcome. Patients...
6.
Hoogsteen I, Marres H, Wijffels K, Rijken P, Peters J, van den Hoogen F, et al.
Clin Cancer Res
. 2005 Jan;
11(1):97-106.
PMID: 15671533
Purpose: Tumor cells undergo a variety of biological changes under sustained hypoxic conditions, allowing cells to survive and retain their clonogenic potential. The purpose of this study is to relate...
7.
Kaanders J, Wijffels K, Marres H, Ljungkvist A, Pop L, van den Hoogen F, et al.
Cancer Res
. 2002 Dec;
62(23):7066-74.
PMID: 12460928
Hypoxia is associated with tumor aggressiveness and is an important cause of resistance to radiation treatment. Assays of tumor hypoxia could provide selection tools for hypoxia-modifying treatments. This study correlated...
8.
Kaanders J, Pop L, Marres H, Bruaset I, van den Hoogen F, Merkx M, et al.
Int J Radiat Oncol Biol Phys
. 2002 Feb;
52(3):769-78.
PMID: 11849800
Purpose: "ARCON" combines accelerated radiotherapy to counteract tumor repopulation with carbogen breathing and nicotinamide to reduce chronic and acute hypoxia. The aim of this Phase II study was to assess...